Skip to main content
    N

    NanoVibronix Inc (NAOV)

    Official site

    MEDICAL DEVICES

    $4.31
    -0.43 (-9.07%)

    Last updated: Dec 10, 2025 at 4:00 PM ET

    NanoVibronix Inc (NAOV) Financials: Revenue, Profit and Cash Flow

    Updated Nov 18, 2025. Financial statements from company filings, amounts in US dollars.

    NanoVibronix reported revenue of $2.56M for the fiscal year ended Dec 31, 2024, up 12.0% from the year before. That year, net income was -$3.71M with a net margin of -144.8%, operating cash flow was -$2.52M and free cash flow was -$2.52M. The quarter ended Sep 30, 2025 had revenue of $722.00K and net income of $510.00K.

    Revenue and Margins

    Over the 9 years to Dec 2024, revenue grew from $147.00K, a compound annual rate of 37.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2024$2.56M+12.0%59.0%-140.0%-144.8%
    Dec 2023$2.28M+203.6%67.3%-150.5%-162.5%
    Dec 2022$752.00K-55.6%22.2%-666.5%-724.5%
    Dec 2021$1.70M+172.1%45.4%-335.3%-842.6%
    Dec 2020$623.00K+17.5%34.3%-757.5%-694.4%
    Dec 2019$530.00K+66.7%53.0%-971.9%-1093.2%
    Dec 2018$318.00K+33.1%50.3%-1353.1%-1306.3%
    Dec 2017$239.00K+4.4%63.2%-1293.3%-2077.4%
    Dec 2016$229.00K+55.8%61.6%-1011.4%-1236.2%
    Dec 2015$147.00KN/A66.7%-968.7%-1961.9%
    Annual, fiscal years ended Dec 2015 to Dec 2024

    Income Statement

    In the fiscal year ended Dec 2024, the net loss was unchanged from the year before. In the quarter ended Sep 2025, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Revenue$2.56M$2.28M$752.00K$1.70M$623.00K$530.00K$318.00K$239.00K$229.00K$147.00K
    Cost of revenue$1.05M$746.00K$585.00K$925.00K$409.00K$249.00K$158.00K$88.00K$88.00K$49.00K
    Gross profit$1.51M$1.54M$167.00K$770.00K$214.00K$281.00K$160.00K$151.00K$141.00K$98.00K
    Research and development$909.00K$185.00K$283.00K$293.00K$171.00K$514.00K$614.00K$693.00K$584.00K$399.00K
    Operating income-$3.58M-$3.44M-$5.01M-$5.68M-$4.72M-$5.15M-$4.30M-$3.09M-$2.32M-$1.42M
    Net income-$3.71M-$3.71M-$5.45M-$14.28M-$4.33M-$5.79M-$4.15M-$4.96M-$2.83M-$2.88M
    EBITDAN/A-$3.44MN/AN/A-$4.16MN/A-$4.28MN/AN/AN/A
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Revenue$722.00K$494.00K$1.02M$444.00K$376.00K$817.00K$921.00K$1.18M$458.00K$294.00K$354.00K-$102.00K
    Gross profitN/A-$35.00K$369.00K$283.00K$133.00K$428.00K$664.00K$737.00K$349.00K$216.00K$235.00K-$300.00K
    Operating incomeN/A-$3.98M-$1.85M-$1.37M-$970.00K-$674.00K-$568.00K-$702.00K-$670.00K-$1.01M-$1.05M-$1.71M
    Net income$510.00K-$156.00K-$2.50M-$1.43M-$998.00K-$688.00K-$588.00K-$813.00K-$727.00K-$1.07M-$1.10M-$2.06M
    Last 12 quarters

    Balance Sheet

    As of Dec 2024, cash and equivalents of $752.00K were 20.7% of total assets of $3.63M, against total liabilities of $3.00M.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Total assets$3.63M$6.67M$5.88M$8.62M$8.23M$2.04M$1.58M$4.87M$494.00K$1.98M
    Current assets$3.33M$6.49M$5.61M$8.34M$7.97M$1.84M$1.23M$4.52M$221.00K$1.78M
    Cash and equivalents$752.00K$3.28M$2.71M$7.74M$7.14M$1.34M$896.00K$4.36M$106.00K$1.61M
    Total liabilities$3.00M$2.69M$2.65M$2.31M$5.83M$688.00K$1.12M$1.23M$2.99M$2.19M
    Shareholder equity$627.00K$3.99M$3.23M$6.31M$2.39M$1.35M$463.00K$3.63M-$2.50M-$209.00K
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total assets$54.38M$51.48M$44.10M$3.63M$4.68M$5.70M$6.24M$6.67M$7.36M$3.83M$4.81M$5.88M
    Total liabilities$11.92M$11.01M$8.43M$3.00M$2.81M$2.85M$2.73M$2.69M$2.67M$2.67M$2.61M$2.65M
    Cash and equivalents$6.95M$4.03M$601.00K$752.00K$1.30M$2.17M$2.70M$3.28M$3.79M$253.00K$1.51M$2.71M
    Shareholder equity$42.46M$40.48M$35.67M$627.00K$1.87M$2.84M$3.50M$3.99M$4.69M$1.17M$2.20M$3.23M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2024.

    Annual

    Line itemDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
    Operating cash flow-$2.52M-$3.60M-$7.04M-$4.37M-$3.39M-$3.87M-$3.55M-$2.18M-$1.53M-$1.48M
    Capital expenditures$3.00K$1.00K$3.00K$3.00K$2.00K$2.00K$8.00K$8.00K$8.00K$1.00K
    Free cash flow-$2.52M-$3.60M-$7.04M-$4.37M-$3.39M-$3.88M-$3.56M-$2.19M-$1.54M-$1.48M
    Investing cash flow-$3.00K-$1.00K-$3.00K-$3.00K-$2.00K-$2.00K-$8.00K-$8.00K-$8.00K-$1.00K
    Financing cash flow$1.00K$4.22M$2.09M$4.58M$9.52M$4.32M$94.00K$6.44M$33.00K$3.00M
    Fiscal years ended Dec 2015 to Dec 2024

    Quarterly

    Line itemSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow-$1.97M-$3.38M-$1.34M-$548.00K-$836.00K-$553.00K-$579.00K-$491.00K-$682.00K-$1.23M-$1.20M-$1.33M
    Capital expenditures$28.00K$4.00K$5.00K$0$0$2.00K$1.00K$0$0$0$1.00K$1.00K
    Free cash flow-$2.00M-$3.39M-$1.35M-$548.00K-$836.00K-$555.00K-$580.00K-$491.00K-$682.00K-$1.23M-$1.20M-$1.33M
    Last 12 quarters

    Frequently Asked Questions About NAOV

    What is NanoVibronix's annual revenue?

    NanoVibronix reported revenue of $2.56M for the fiscal year ended Dec 31, 2024.

    How fast is NanoVibronix's revenue growing?

    Revenue was up 12.0% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 14.7%.

    Is NanoVibronix profitable?

    No. NanoVibronix reported net income of -$3.71M for the fiscal year ended Dec 31, 2024, with a net margin of -144.8%.

    How much free cash flow does NAOV generate?

    For the fiscal year ended Dec 31, 2024, operating cash flow of -$2.52M minus capital expenditures of $3.00K produced free cash flow of -$2.52M.

    How much debt does NanoVibronix have?

    The balance sheet dated Dec 31, 2024 reported cash and equivalents of $752.00K.